Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI (EASY TAVI)
Aortic Valve Stenosis
About this trial
This is an interventional other trial for Aortic Valve Stenosis focused on measuring TAVI, aortic valve bioprothesis, TAVI simplification, aortic stenosis, rapid left ventricular pacing, TAVR
Eligibility Criteria
Inclusion Criteria:
- Subject is eligible for a TAVI
- Access considered for aortic valve bioprothesis delivery is transfemoral
- Aortic valve bioprothesis considered is Edwards Sapien 3® et/ou XT®
- Subject is ≥ 18 years of age
- Subject has signed informed consent form
Exclusion Criteria:
- Pregnancy
- Subject already included in this study
- Subject included in another study and whose inclusion in EASY TAVI implies a deviation in either study
Sites / Locations
- CHU Clermont Ferrand
- Centre Hospitalier Annecy Genevois
- Clinique du Tonkin
- Institut Mutualiste Montsouris
- Groupement Hospitalier Mutualiste de Grenoble
- Hôpital privé Jacques Cartier
- Clinique Saint-Hilaire
- Clinique Pasteur
- Institut Arnault Tzanck
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Right ventricular pacing
Left ventricular pacing
Rapid pacing during TAVI is provided by a temporary pacing catheter placed in the right ventricle. An additional venous vascular access is required.
Rapid pacing during TAVI is provided by the valve delivery guidewire inserted into the left ventricle using two alligator clamps. One clamp is attached directly to the skin at the femoral entry site, the other is attached to the body of the valve delivery guidewire. No additional venous vascular access is required.